Acute 0 5 0 5 B-cancer
Leukemias 6 15 6 15 I-cancer
in 16 18 16 18 O
2nd 19 22 19 22 O
or 23 25 23 25 O
subsequent 26 36 26 36 O
remission 37 46 37 46 O

Acute 0 5 47 52 B-cancer
Lymphoblastic 6 19 53 66 I-cancer
Leukemia 20 28 67 75 I-cancer
in 29 31 76 78 O
high 32 36 79 83 O
risk 37 41 84 88 O
CR1 42 45 89 92 O

Acute 0 5 93 98 B-cancer
Myelogeneous 6 18 99 111 I-cancer
Leukemia 19 27 112 120 I-cancer
in 28 30 121 123 O
high 31 35 124 128 O
risk 36 40 129 133 O
CR1 41 44 134 137 B-clinical_variable

Acute 0 5 138 143 B-cancer
leukemias 6 15 144 153 I-cancer
( 16 17 154 155 O
includes 17 25 155 163 O
T 26 27 164 165 B-cancer
lymphoblastic 28 41 166 179 I-cancer
lymphoma 42 50 180 188 I-cancer
) 50 51 188 189 O

Adverse 0 7 190 197 O
cytogenetics 8 20 198 210 O
such 21 25 211 215 O
as 26 28 216 218 O
t(9;22 29 35 219 225 O
) 35 36 225 226 O
, 36 37 226 227 O
t(1;19 38 44 228 234 O
) 44 45 234 235 O
, 45 46 235 236 O
t(4;11 47 53 237 243 O
) 53 54 243 244 O
, 54 55 244 245 O
MLL 56 59 246 249 B-cancer
rearrangements 60 74 250 264 O
White 75 80 265 270 B-clinical_variable
blood 81 86 271 276 I-clinical_variable
cell 87 91 277 281 I-clinical_variable
counts 92 98 282 288 I-clinical_variable
> 99 100 289 290 O
30,000 100 106 290 296 B-lower_bound
/ 106 107 296 297 I-lower_bound
mcL 107 110 297 300 I-lower_bound
Patients 111 119 301 309 O
over 120 124 310 314 O
30 125 127 315 317 B-lower_bound
years 128 133 318 323 I-lower_bound
of 134 136 324 326 O
age 137 140 327 330 B-age
Time 141 145 331 335 O
to 146 148 336 338 O
complete 149 157 339 347 O
remission 158 167 348 357 O
> 168 169 358 359 O
4 169 170 359 360 B-lower_bound
weeks 171 176 361 366 I-lower_bound
Presence 177 185 367 375 O
of 186 188 376 378 O
extramedullary 189 203 379 393 B-chronic_disease
disease 204 211 394 401 I-chronic_disease

Age 0 3 402 405 B-age
≥ 4 5 406 407 O
18 6 8 408 410 B-lower_bound
years 9 14 411 416 I-lower_bound

Age 0 3 417 420 B-age
< 3 4 420 421 O
70 5 7 422 424 B-upper_bound

Biphenotypic 0 12 425 437 B-cancer
/ 12 13 437 438 O
Undifferentiated 13 29 438 454 B-cancer
Leukemias 30 39 455 464 I-cancer
in 40 42 465 467 O
1st 43 46 468 471 O
or 47 49 472 474 O
subsequent 50 60 475 485 O
CR 61 63 486 488 O

Burkitt 0 7 489 496 B-cancer
's 7 9 496 498 I-cancer
lymphoma 10 18 499 507 I-cancer
: 18 19 507 508 O
second 20 26 509 515 O
or 27 29 516 518 O
subsequent 30 40 519 529 O
CR 41 43 530 532 O

Cardiac 0 7 533 540 O
: 7 8 540 541 O
left 9 13 542 546 B-clinical_variable
ventricular 14 25 547 558 I-clinical_variable
ejection 26 34 559 567 I-clinical_variable
fraction 35 43 568 576 I-clinical_variable
at 44 46 577 579 O
rest 47 51 580 584 O
must 52 56 585 589 O
be 57 59 590 592 O
≥ 60 61 593 594 O
35 62 64 595 597 B-lower_bound
% 64 65 597 598 I-lower_bound

Chemotherapy 0 12 599 611 B-treatment
- 12 13 611 612 O
sensitive 13 22 612 621 O
( 23 24 622 623 O
complete 24 32 623 631 O
or 33 35 632 634 O
partial 36 43 635 642 O
response 44 52 643 651 O

Current 0 7 652 659 O
uncontrolled 8 20 660 672 O
bacterial 21 30 673 682 B-chronic_disease
, 30 31 682 683 O
viral 32 37 684 689 B-chronic_disease
or 38 40 690 692 O
fungal 41 47 693 699 B-chronic_disease
infection 48 57 700 709 I-chronic_disease
( 58 59 710 711 O
currently 59 68 711 720 O
taking 69 75 721 727 O
medication 76 86 728 738 B-treatment
with 87 91 739 743 O
evidence 92 100 744 752 O
of 101 103 753 755 O
progression 104 115 756 767 O
of 116 118 768 770 O
clinical 119 127 771 779 O
symptoms 128 136 780 788 O
or 137 139 789 791 O
radiologic 140 150 792 802 O
findings 151 159 803 811 O
) 159 160 811 812 O

Donors 0 6 813 819 O
must 7 11 820 824 O
be 12 14 825 827 O
HLA 15 18 828 831 B-treatment
- 18 19 831 832 I-treatment
haploidentical 19 33 832 846 I-treatment
first 34 39 847 852 O
- 39 40 852 853 O
degree 40 46 853 859 O
or 47 49 860 862 O
second 50 56 863 869 O
degree 57 63 870 876 O
relatives 64 73 877 886 O
of 74 76 887 889 O
the 77 80 890 893 O
patient 81 88 894 901 O

Greater 0 7 902 909 O
than 8 12 910 914 O
1 13 14 915 916 O
cycle 15 20 917 922 O
of 21 23 923 925 O
induction 24 33 926 935 B-treatment
therapy 34 41 936 943 I-treatment
required 42 50 944 952 O
to 51 53 953 955 O
achieve 54 61 956 963 O
remission 62 71 964 973 O
Preceding 72 81 974 983 O
myelodysplastic 82 97 984 999 B-cancer
syndrome 98 106 1000 1008 I-cancer
( 107 108 1009 1010 I-cancer
MDS 108 111 1010 1013 I-cancer
) 111 112 1013 1014 I-cancer
Presence 113 121 1015 1023 O
of 122 124 1024 1026 O
Flt3 125 129 1027 1031 O
abnormalities 130 143 1032 1045 O
FAB 144 147 1046 1049 B-cancer
M6 148 150 1050 1052 I-cancer
or 151 153 1053 1055 O
M7 154 156 1056 1058 O
leukemia 157 165 1059 1067 B-cancer

Hepatic 0 7 1068 1075 O
: 7 8 1075 1076 O
bilirubin 9 18 1077 1086 B-clinical_variable
≤ 19 20 1087 1088 O
2.5 21 24 1089 1092 B-upper_bound
mg 25 27 1093 1095 I-upper_bound
/ 27 28 1095 1096 I-upper_bound
dL 28 30 1096 1098 I-upper_bound
; 30 31 1098 1099 O
and 32 35 1100 1103 O
ALT 36 39 1104 1107 B-clinical_variable
, 39 40 1107 1108 O
AST 41 44 1109 1112 B-clinical_variable
, 44 45 1112 1113 O
and 46 49 1114 1117 O
Alkaline 50 58 1118 1126 B-clinical_variable
Phosphatase 59 70 1127 1138 I-clinical_variable
< 71 72 1139 1140 O
5 73 74 1141 1142 B-upper_bound
x 75 76 1143 1144 I-upper_bound
ULN 77 80 1145 1148 I-upper_bound

High 0 4 1149 1153 O
- 4 5 1153 1154 O
risk 5 9 1154 1158 O
MDS 10 13 1159 1162 B-chronic_disease
status 14 20 1163 1169 O
- 20 21 1169 1170 O
post 21 25 1170 1174 O
cytotoxic 26 35 1175 1184 B-treatment
chemotherapy 36 48 1185 1197 I-treatment

Lymphoma 0 8 1198 1206 B-cancer

Marginal 0 8 1207 1215 B-cancer
zone 9 13 1216 1220 I-cancer
B 14 15 1221 1222 I-cancer
- 15 16 1222 1223 I-cancer
cell 16 20 1223 1227 I-cancer
lymphoma 21 29 1228 1236 I-cancer
or 30 32 1237 1239 O
follicular 33 43 1240 1250 B-cancer
lymphoma 44 52 1251 1259 I-cancer
that 53 57 1260 1264 O
has 58 61 1265 1268 O
progressed 62 72 1269 1279 O
after 73 78 1280 1285 O
at 79 81 1286 1288 O
least 82 87 1289 1294 O
two 88 91 1295 1298 B-lower_bound
prior 92 97 1299 1304 I-lower_bound
therapies 98 107 1305 1314 B-treatment
( 108 109 1315 1316 O
excluding 109 118 1316 1325 O
single 119 125 1326 1332 B-treatment
agent 126 131 1333 1338 I-treatment
Rituxan 132 139 1339 1346 I-treatment
) 139 140 1346 1347 O
and 141 144 1348 1351 O
are 145 148 1352 1355 O
ineligible 149 159 1356 1366 O
for 160 163 1367 1370 O
an 164 166 1371 1373 O
autologous 167 177 1374 1384 B-treatment
transplant 178 188 1385 1395 I-treatment
or 189 191 1396 1398 O
relapsed 192 200 1399 1407 O
/ 200 201 1407 1408 O
progressed 201 211 1408 1418 O
after 212 217 1419 1424 O
autologous 218 228 1425 1435 B-treatment
stem 229 233 1436 1440 I-treatment
cell 234 238 1441 1445 I-treatment
transplant 239 249 1446 1456 I-treatment

Myelofibrosis 0 13 1457 1470 B-cancer

Performance 0 11 1471 1482 B-clinical_variable
status 12 18 1483 1489 I-clinical_variable
: 18 19 1489 1490 O
Karnofsky 20 29 1491 1500 B-clinical_variable
/ 29 30 1500 1501 O
Lansky 30 36 1501 1507 B-clinical_variable
score 37 42 1508 1513 I-clinical_variable
≥ 43 44 1514 1515 O
60 45 47 1516 1518 B-lower_bound
% 47 48 1518 1519 I-lower_bound

Positive 0 8 1520 1528 O
anti 9 13 1529 1533 O
- 13 14 1533 1534 O
donor 14 19 1534 1539 O
HLA 20 23 1540 1543 B-clinical_variable
antibody 24 32 1544 1552 O

Pregnancy 0 9 1553 1562 B-pregnancy
or 10 12 1563 1565 O
breast 13 19 1566 1572 O
- 19 20 1572 1573 O
feeding 20 27 1573 1580 O

Pulmonary 0 9 1581 1590 O
: 9 10 1590 1591 O
FEV1 11 15 1592 1596 B-clinical_variable
, 15 16 1596 1597 O
FVC 17 20 1598 1601 B-clinical_variable
, 20 21 1601 1602 O
DLCO 22 26 1603 1607 B-clinical_variable
( 27 28 1608 1609 O
diffusion 28 37 1609 1618 O
capacity 38 46 1619 1627 O
) 46 47 1627 1628 O
≥ 48 49 1629 1630 O
40 50 52 1631 1633 B-lower_bound
% 52 53 1633 1634 I-lower_bound
predicted 54 63 1635 1644 O
( 64 65 1645 1646 O
corrected 65 74 1646 1655 O
for 75 78 1656 1659 O
hemoglobin 79 89 1660 1670 B-clinical_variable
) 89 90 1670 1671 O
; 90 91 1671 1672 O
if 92 94 1673 1675 O
unable 95 101 1676 1682 O
to 102 104 1683 1685 O
perform 105 112 1686 1693 O
pulmonary 113 122 1694 1703 O
function 123 131 1704 1712 O
tests 132 137 1713 1718 O
, 137 138 1718 1719 O
then 139 143 1720 1724 O
O2 144 146 1725 1727 O
saturation 147 157 1728 1738 O
> 158 159 1739 1740 O
92 160 162 1741 1743 B-lower_bound
% 162 163 1743 1744 I-lower_bound
on 164 166 1745 1747 O
room 167 171 1748 1752 O
air 172 175 1753 1756 O

Remission 0 9 1757 1766 B-clinical_variable
is 10 12 1767 1769 O
defined 13 20 1770 1777 O
as 21 23 1778 1780 O
< 24 25 1781 1782 O
5 26 27 1783 1784 B-upper_bound
% 27 28 1784 1785 I-upper_bound
blasts 29 35 1786 1792 O
with 36 40 1793 1797 O
no 41 43 1798 1800 O
morphological 44 57 1801 1814 O
characteristics 58 73 1815 1830 O
of 74 76 1831 1833 O
acute 77 82 1834 1839 O
leukemia 83 91 1840 1848 B-chronic_disease
( 92 93 1849 1850 O
e.g. 93 97 1850 1854 O
, 97 98 1854 1855 O
Auer 99 103 1856 1860 O
Rods 104 108 1861 1865 O
) 108 109 1865 1866 O
in 110 112 1867 1869 O
a 113 114 1870 1871 O
bone 115 119 1872 1876 O
marrow 120 126 1877 1883 O
with 127 131 1884 1888 O
> 132 133 1889 1890 O
20 134 136 1891 1893 B-lower_bound
% 136 137 1893 1894 I-lower_bound
cellularity 138 149 1895 1906 B-clinical_variable
, 149 150 1906 1907 O
peripheral 151 161 1908 1918 B-clinical_variable
blood 162 167 1919 1924 I-clinical_variable
counts 168 174 1925 1931 I-clinical_variable
showing 175 182 1932 1939 O
ANC 183 186 1940 1943 B-clinical_variable
> 187 188 1944 1945 O
1000 188 192 1945 1949 B-lower_bound
/ 192 193 1949 1950 I-lower_bound
ul 193 195 1950 1952 I-lower_bound
, 195 196 1952 1953 O
including 197 206 1954 1963 O
patients 207 215 1964 1972 O
in 216 218 1973 1975 O
CRp 219 222 1976 1979 O

Renal 0 5 1980 1985 O
: 5 6 1985 1986 O
serum 7 12 1987 1992 B-clinical_variable
creatinine 13 23 1993 2003 I-clinical_variable
within 24 30 2004 2010 O
normal 31 37 2011 2017 O
range 38 43 2018 2023 O
for 44 47 2024 2027 O
age 48 51 2028 2031 B-age
, 51 52 2031 2032 O
or 53 55 2033 2035 O
if 56 58 2036 2038 O
serum 59 64 2039 2044 O
creatinine 65 75 2045 2055 O
outside 76 83 2056 2063 O
normal 84 90 2064 2070 O
range 91 96 2071 2076 O
for 97 100 2077 2080 O
age 101 104 2081 2084 O
, 104 105 2084 2085 O
then 106 110 2086 2090 O
renal 111 116 2091 2096 O
function(creatinine 117 136 2097 2116 O
clearance 137 146 2117 2126 I-clinical_variable
or 147 149 2127 2129 O
GFR 150 153 2130 2133 B-clinical_variable
) 153 154 2133 2134 O
> 155 156 2135 2136 O
40 157 159 2137 2139 B-lower_bound
mL 160 162 2140 2142 I-lower_bound
/ 162 163 2142 2143 I-lower_bound
min/1.73m2 163 173 2143 2153 I-lower_bound

Weight 0 6 2154 2160 B-clinical_variable
≥ 7 8 2161 2162 O
40 9 11 2163 2165 B-lower_bound
kg 12 14 2166 2168 I-lower_bound

who 0 3 2169 2172 O
have 4 8 2173 2177 O
received 9 17 2178 2186 O
a 18 19 2187 2188 O
prior 20 25 2189 2194 B-treatment
allogeneic 26 36 2195 2205 I-treatment
HSCT 37 41 2206 2210 I-treatment
and 42 45 2211 2214 O
who 46 49 2215 2218 O
have 50 54 2219 2223 O
either 55 61 2224 2230 O
rejected 62 70 2231 2239 O
their 71 76 2240 2245 O
grafts 77 83 2246 2252 O
or 84 86 2253 2255 O
who 87 90 2256 2259 O
have 91 95 2260 2264 O
become 96 102 2265 2271 O
tolerant 103 111 2272 2280 O
of 112 114 2281 2283 O
their 115 120 2284 2289 O
grafts 121 127 2290 2296 O
with 128 132 2297 2301 O
no 133 135 2302 2304 O
active 136 142 2305 2311 O
GVHD 143 147 2312 2316 B-chronic_disease
requiring 148 157 2317 2326 O
immunosuppressive 158 175 2327 2344 B-treatment
therapy 176 183 2345 2352 I-treatment

